Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.
Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Holt EH, Hui P, Umbricht CB, Basaria S, Ewertz M, Tufaro AP, Califano JA, Ringel MD, Zeiger MA, Sidransky D, Ladenson PW. Xing M, et al. Among authors: rhoden kj. J Clin Endocrinol Metab. 2005 Dec;90(12):6373-9. doi: 10.1210/jc.2005-0987. Epub 2005 Sep 20. J Clin Endocrinol Metab. 2005. PMID: 16174717
Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer.
Hu S, Liu D, Tufano RP, Carson KA, Rosenbaum E, Cohen Y, Holt EH, Kiseljak-Vassiliades K, Rhoden KJ, Tolaney S, Condouris S, Tallini G, Westra WH, Umbricht CB, Zeiger MA, Califano JA, Vasko V, Xing M. Hu S, et al. Among authors: rhoden kj. Int J Cancer. 2006 Nov 15;119(10):2322-9. doi: 10.1002/ijc.22110. Int J Cancer. 2006. PMID: 16858683
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ, Unger K, Salvatore G, Yilmaz Y, Vovk V, Chiappetta G, Qumsiyeh MB, Rothstein JL, Fusco A, Santoro M, Zitzelsberger H, Tallini G. Rhoden KJ, et al. J Clin Endocrinol Metab. 2006 Jun;91(6):2414-23. doi: 10.1210/jc.2006-0240. Epub 2006 Apr 4. J Clin Endocrinol Metab. 2006. PMID: 16595592
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study.
Tallini G, de Biase D, Durante C, Acquaviva G, Bisceglia M, Bruno R, Bacchi Reggiani ML, Casadei GP, Costante G, Cremonini N, Lamartina L, Meringolo D, Nardi F, Pession A, Rhoden KJ, Ronga G, Torlontano M, Verrienti A, Visani M, Filetti S. Tallini G, et al. Among authors: rhoden kj. Mod Pathol. 2015 Oct;28(10):1343-59. doi: 10.1038/modpathol.2015.92. Epub 2015 Aug 14. Mod Pathol. 2015. PMID: 26271724 Free article.
Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk Stratification.
Tallini G, De Leo A, Repaci A, de Biase D, Bacchi Reggiani ML, Di Nanni D, Ambrosi F, Di Gioia C, Grani G, Rhoden KJ, Solaroli E, Monari F, Filetti S, Durante C. Tallini G, et al. Among authors: rhoden kj. Cancers (Basel). 2020 Jan 19;12(1):246. doi: 10.3390/cancers12010246. Cancers (Basel). 2020. PMID: 31963890 Free PMC article.
49 results